0.66
-0.1444(-17.95%)
Currency In USD
Address
One Gateway Center
Newton, MA 02458
United States of America
Phone
844 902 6100
Website
Sector
Healthcare
Industry
Biotechnology
Employees
30
First IPO Date
April 14, 2004
| Name | Title | Pay | Year Born |
| Mr. Christopher Schelling | Founder, President, Chief Executive Officer & Director | 739,815 | 1976 |
| Mr. Jefferson E. Davis | Chief Business Officer | 326,667 | 1967 |
| Dr. Adrian Quartel FFPM, M.D. | Chief Medical Officer | 421,649 | 1967 |
| Mr. Donald R. Joseph J.D. | Chief Legal Officer & Secretary | 490,280 | 1954 |
| Mr. Harry S. Palmin | Chief Financial Officer | 545,360 | 1970 |
| Mr. Jason Kneeland CPA | Vice President of Finance & Controller | 0 | N/A |
| Mr. Matthew T. Seibt | Chief Commercial Officer | 0 | 1971 |
| Mr. John Michael Klopp | Chief Technical Officer | 0 | 1975 |
| Mr. Bernie Paul | Chief People Officer | 0 | 1959 |
| Ms. Tanya Hayden | Chief Operating Officer | 0 | 1980 |
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts.